Highlights
- Market Cap
- $69.10B
- Enterprise Value
- $62.10B
- EPS (TTM)
- $25.22
- PE Ratio
- 12.35
- Total Revenue (TTM)
- $198.69B
- Gross Profit (TTM)
- $111.58B
- EBITDA (TTM)
- $9.57B
- Year Range
- $273.71 - $443.29
- Target Price
- $392.60
- ROA (TTM)
- 4.66%
- ROE (TTM)
- 12.90%
Share Price Chart
Loading graphics...
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Performance
ELV Performance Chart
Elevance Health Inc (ELV) is down 10.6% since the beginning of the year. At $312 per share, ELV is trading 29.7% below its 52-week high of $443. Investors who bought $1,000 worth of ELV shares 5 years ago would now be looking at an investment worth $926.
Loading graphics...
Returns By Period
Elevance Health Inc (ELV) has returned -10.58% so far this year and -27.08% over the past 12 months. Over the last ten years, ELV has returned 9.63% per year, falling short of the S&P 500 Index benchmark, which averaged 12.70% annually.
Elevance Health Inc
- 1D
- -1.69%
- 1M
- 7.50%
- YTD
- -10.58%
- 6M
- -10.81%
- 1Y
- -27.08%
- 3Y*
- -12.60%
- 5Y*
- -1.52%
- 10Y*
- 9.63%
Benchmark (S&P 500 Index)
- 1D
- -0.11%
- 1M
- 0.61%
- YTD
- -0.42%
- 6M
- 4.03%
- 1Y
- 29.40%
- 3Y*
- 18.38%
- 5Y*
- 10.55%
- 10Y*
- 12.70%
ELV Monthly Returns History
Based on dividend-adjusted daily data since Oct 30, 2001, ELV's average daily return is +0.07%, while the average monthly return is +1.31%. At this rate, an investment would double in approximately 4.4 years.
Historically, 59% of months were positive and 41% were negative. The best month was Nov 2004 with a return of +26.0%, while the worst month was Mar 2008 at -37.0%. The longest winning streak lasted 11 consecutive months, and the longest losing streak was 6 months.
On a daily basis, ELV closed higher 52% of trading days. The best single day was Oct 13, 2008 with a return of +18.4%, while the worst single day was Mar 11, 2008 at -28.3%.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | -1.37% | -7.44% | -7.95% | 6.42% | -10.58% | ||||||||
| 2025 | 7.26% | 0.30% | 10.05% | -3.31% | -8.74% | 1.78% | -27.22% | 12.57% | 1.96% | -1.83% | 6.64% | 4.17% | -3.14% |
| 2024 | 4.64% | 1.58% | 3.78% | 1.94% | 1.87% | 0.93% | -1.81% | 4.67% | -6.34% | -21.97% | 0.30% | -8.98% | -20.72% |
| 2023 | -2.53% | -6.06% | -1.79% | 1.92% | -4.44% | -0.47% | 6.15% | -6.28% | -1.16% | 3.37% | 6.53% | -1.35% | -6.89% |
| 2022 | -4.86% | 2.46% | 9.02% | 2.18% | 1.53% | -5.06% | -1.14% | 1.68% | -6.12% | 20.37% | -2.53% | -3.51% | 11.83% |
| 2021 | -7.51% | 2.09% | 18.79% | 5.69% | 4.96% | -3.85% | 0.58% | -2.31% | -0.32% | 16.72% | -6.64% | 14.43% | 46.12% |
Benchmark Metrics
Elevance Health Inc has an annualized alpha of 9.90%, beta of 0.79, and R² of 0.24 versus S&P 500 Index. Calculated based on daily prices since October 31, 2001.
- This stock participates in less of S&P 500 Index's moves in both directions, but captures a larger share of gains (87.79%) than losses (62.80%) — typical of diversified or defensive assets.
- R² of 0.24 means this stock moves largely independently of S&P 500 Index — capture ratios reflect limited market correlation rather than active downside protection. Consider using a more representative benchmark.
- Alpha
- 9.90%
- Beta
- 0.79
- R²
- 0.24
- Upside Capture
- 87.79%
- Downside Capture
- 62.80%
Return for Risk
Risk / Return Rank
ELV ranks 11 for risk / return — in the bottom 11% of stocks on our site. This means you're taking on significantly more risk than the returns justify. Consider whether the potential upside is worth the volatility, or explore alternatives with better risk / return profiles.
Return / Risk — by metrics
The table below present risk-adjusted performance metrics for Elevance Health Inc (ELV) and compare them to a chosen benchmark (S&P 500 Index).
| ELV | Benchmark | Difference | |
|---|---|---|---|
Sharpe ratioReturn per unit of total volatility | -0.69 | 2.23 | -2.92 |
Sortino ratioReturn per unit of downside risk | -0.72 | 3.12 | -3.83 |
Omega ratioGain probability vs. loss probability | 0.89 | 1.42 | -0.52 |
Calmar ratioReturn relative to maximum drawdown | -0.70 | 4.05 | -4.74 |
Martin ratioReturn relative to average drawdown | -1.11 | 17.91 | -19.02 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Explore ELV risk-adjusted metrics in detail
Dive deeper into individual metrics with historical trends, benchmark comparisons, and performance across different time periods.
Dividends
Dividend History
Elevance Health Inc provided a 2.20% dividend yield over the last twelve months, with an annual payout of $6.85 per share. The company has been increasing its dividends for 14 consecutive years.
| Period | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Dividend | $6.85 | $6.84 | $6.52 | $5.92 | $5.12 | $4.52 | $3.80 | $3.20 | $3.00 | $2.70 | $2.60 | $2.50 |
Dividend yield | 2.20% | 1.95% | 1.77% | 1.26% | 1.00% | 0.98% | 1.18% | 1.06% | 1.14% | 1.20% | 1.81% | 1.79% |
Monthly Dividends
The table displays the monthly dividend distributions for Elevance Health Inc. The dividends shown in the table have been adjusted to account for any splits that may have occurred.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | $0.00 | $0.00 | $1.72 | $0.00 | $1.72 | ||||||||
| 2025 | $0.00 | $0.00 | $1.71 | $0.00 | $0.00 | $1.71 | $0.00 | $0.00 | $1.71 | $0.00 | $0.00 | $1.71 | $6.84 |
| 2024 | $0.00 | $0.00 | $1.63 | $0.00 | $0.00 | $1.63 | $0.00 | $0.00 | $1.63 | $0.00 | $0.00 | $1.63 | $6.52 |
| 2023 | $0.00 | $0.00 | $1.48 | $0.00 | $0.00 | $1.48 | $0.00 | $0.00 | $1.48 | $0.00 | $0.00 | $1.48 | $5.92 |
| 2022 | $0.00 | $0.00 | $1.28 | $0.00 | $0.00 | $1.28 | $0.00 | $0.00 | $1.28 | $0.00 | $0.00 | $1.28 | $5.12 |
| 2021 | $0.00 | $0.00 | $1.13 | $0.00 | $0.00 | $1.13 | $0.00 | $0.00 | $1.13 | $0.00 | $0.00 | $1.13 | $4.52 |
Dividend Yield & Payout
Dividend Yield
Elevance Health Inc has a dividend yield of 2.20%, which is quite average when compared to the overall market.
Payout Ratio
Elevance Health Inc has a payout ratio of 26.93%, which is quite average when compared to the overall market. This suggests that Elevance Health Inc strikes a balance between reinvesting profits for growth and paying dividends to shareholders.
Drawdowns
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.
Loading graphics...
Worst Drawdowns
The table below displays the maximum drawdowns of the Elevance Health Inc. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.
The maximum drawdown for the Elevance Health Inc was 67.19%, occurring on Nov 20, 2008. Recovery took 1170 trading sessions.
The current Elevance Health Inc drawdown is 42.77%.
Depth | Start | To Bottom | Bottom | To Recover | End | Total |
|---|---|---|---|---|---|---|
| -67.19% | Dec 26, 2007 | 230 | Nov 20, 2008 | 1170 | Jul 18, 2013 | 1400 |
| -50.38% | Sep 4, 2024 | 228 | Aug 1, 2025 | — | — | — |
| -44.12% | Feb 27, 2019 | 270 | Mar 23, 2020 | 150 | Oct 23, 2020 | 420 |
| -30.85% | Jun 23, 2015 | 159 | Feb 8, 2016 | 267 | Mar 1, 2017 | 426 |
| -27.33% | Jun 13, 2002 | 169 | Feb 12, 2003 | 67 | May 20, 2003 | 236 |
Volatility
Volatility Chart
The chart below shows the rolling one-month volatility.
Loading graphics...
Financials
Financial Performance
The chart below illustrates the trends in the financial health of Elevance Health Inc over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.
Valuation
The Valuation section provides an overview of how Elevance Health Inc is priced in the market compared to other companies in the Healthcare Plans industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.
PE Ratio
The chart displays the Price-to-Earnings (P/E) ratio for ELV, comparing it with other companies in the Healthcare Plans industry. Currently, ELV has a P/E ratio of 12.4. This P/E ratio is considered low compared to industry peers, which may suggest that the stock is undervalued or that the company has weaker growth prospects.
PS Ratio
This chart shows the Price-to-Sales (P/S) ratio for ELV relative to other companies in the Healthcare Plans industry. Currently, ELV has a P/S ratio of 0.4. This P/S ratio falls within the average range for the industry, suggesting the stock is fairly valued based on its revenue.
PB Ratio
The chart illustrates the Price-to-Book (P/B) ratio for ELV in comparison with other companies in the Healthcare Plans industry. Currently, ELV has a P/B value of 1.6. This P/B ratio is in line with the industry average, suggesting the stock is valued fairly in relation to its book value.
Income Statement
| TTM | |
|---|---|
Revenue | — |
Total Revenue | — |
Cost Of Revenue | — |
Gross Profit | — |
Operating Expenses | — |
Selling, General & Admin Expenses | — |
R&D Expenses | — |
Depreciation And Amortization | — |
Total Operating Expenses | — |
Income | — |
Income Before Tax | — |
Operating Income | — |
EBITDA | — |
EBIT | — |
Earnings From Continuing Operations | — |
Net Income | — |
Income Tax Expense | — |
Other Non-Operating Income (Expenses) | — |
Extraordinary Items | — |
Discontinued Operations | — |
Effect Of Accounting Charges | — |
Non Recurring | — |
Minority Interest | — |
Other Items | — |
Interest Income | — |
Interest Expense | — |
Net Interest Income | — |
Build a portfolio with ELV
Add Elevance Health Inc to a portfolio and analyze allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Analyzer with ELV